TD Cowen on Monte Rosa Therapeutics (GLUE): 'the overall database shows little of concern'
Tweet Send to a Friend
TD Cowen analyst Marc Frahm reiterated a Buy rating on Monte Rosa Therapeutics (NASDAQ: GLUE).The analyst comments "Monte Rosa presented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
